NOVTNovanta Inc.
$141.41+23% 1Y
$141.41
$99.2252 weeks$168.82
Latest close: back above its 200-day averageOct 9, 2026what changed →
The financials
Novanta Inc. by the numbers
Novanta Inc. (NOVT) reported revenue of $266M in Q2 2026 (quarter ended Jul 3, 2026), up 10% from the same quarter a year earlier. That came with a gross margin of 45% and net income of $13M (4.7% of revenue). For the full year FY2025, revenue was $981M (+3.3% year on year) and net income $54M. Its largest segment in Q2 2026 was Robotics And Automation at $88M, 33% of the disclosed total, ahead of Advanced Surgery at 25%. The next results filing is expected around Nov 2, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $266M | $241M | +10% |
| Gross profit | $121M | $107M | +13% |
| Operating income | $18M | $15M | +21% |
| Net income | $13M | $4.5M | +179% |
| Diluted EPS | $0.30 | $0.12 | +150% |
| Operating | Revenue | Share |
|---|---|---|
| Robotics And Automation | $88M | 33% |
| Advanced Surgery | $68M | 25% |
| Precision Medicine | $62M | 23% |
| Precision Manufacturing | $48M | 18% |
Business segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Jun 2026Total $265.8M (+3.1%)
Robotics And Automation grew +14% year on yearPrecision Medicine +4.9% year on year
Segment Latestquarter on quarteryear on year
- Robotics And Automation$88.4M$88.4Mquarter on quarter +5.0%year on year +14%+5.0%+14%
- Advanced Surgery$67.5M$67.5Mquarter on quarter +8.0%year on year +12%+8.0%+12%
- Precision Medicine$62.1M$62.1Mquarter on quarter -2.9%year on year +4.9%-2.9%+4.9%
- Precision Manufacturing$47.8M$47.8Mquarter on quarter +1.6%year on year +9.1%+1.6%+9.1%
Scientific & Technical Instruments
Ranks #6 of 12 by RyuScore